Personalization of Long-Term Antiplatelet Therapy Using a Novel Combined Demographic/Pharmacogenomic Strategy - the RAPID EXTEND Randomized Study
Latest Information Update: 16 Dec 2024
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes; Arterial occlusive disorders; Thrombosis
- Focus Therapeutic Use
- Acronyms RAPID EXTEND
Most Recent Events
- 11 Dec 2024 Planned End Date changed from 1 Sep 2024 to 1 Sep 2026.
- 11 Dec 2024 Planned primary completion date changed from 1 Mar 2024 to 1 Mar 2025.
- 12 Jan 2024 Planned End Date changed from 1 Oct 2023 to 1 Sep 2024.